MIQE Guidelines for qPCR: What Reviewers Expect in Your Methods Section

The MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) were published in 2009 to fix a reproducibility problem: a decade of qPCR papers with methods sections so thin that nobody could replicate them. MIQE is a reporting standard—it tells you what to disclose, not how to run the experiment. Two very different experimental designs can both be MIQE-compliant if properly reported. A methodologically sound experiment can still be MIQE-noncompliant if the reporting is incomplete.

MIQE 2.0 was published in 2025, tightening several items and adding new ones for modern workflows (digital PCR, multiplex assays, automated analysis tools). If you are submitting to a journal that enforces MIQE (Nucleic Acids Research, Clinical Chemistry, Methods, BMC Genomics, and a growing list), the reviewer checklist is explicit. This article walks through the seven items reviewers flag most often—the ones that turn a good experiment into a revision cycle.

1. Reference Gene Validation Is Undocumented

The single most common MIQE failure: the manuscript uses a reference gene (often GAPDH or beta-actin) without reporting any validation that the gene is stable under the experimental conditions. MIQE classifies reference gene validation as Essential. Default choices from prior publications do not count; a reviewer will ask for direct evidence from your system.

What the reviewer wants to see in the methods section:

• The candidate gene panel (at least 3 genes tested, ideally 4 to 8)
• The algorithm(s) used for stability analysis (geNorm, NormFinder, or BestKeeper)
• The M-value or stability value reported for the selected gene(s)
• Justification if only one reference gene was used instead of the recommended geometric mean of two or more

A one-sentence claim that “GAPDH was used as a reference gene” is the clearest signal a reviewer gets that no validation was done. That sentence triggers a revision request more often than any other phrase in a qPCR methods section.

2. Primer Efficiency Is Not Reported

MIQE Essential requires primer efficiency reporting for every primer pair in the study. “Primers were designed using Primer3” is not efficiency reporting. Reviewers want:

• The method used to determine efficiency (standard curve dilution series is the most common)
• The efficiency value as a percentage (90% to 110% is acceptable; anything outside requires explanation)
• The R² of the standard curve regression (should be > 0.98)
• The dynamic range over which efficiency was validated

3. Controls Are Missing or Incomplete

MIQE Essential requires reporting of:

• No-template control (NTC): a reaction with water instead of template, per primer pair, on every plate. Detects reagent contamination.
• No-reverse-transcriptase control (NRT): a mock RT with no enzyme. Detects genomic DNA contamination. Essential when primers do not span an intron.
• Positive control where available: a known-positive sample to confirm the assay worked.

A common omission is reporting NTC but not NRT. If your primers amplify genomic DNA (which is common with single-exon genes or primers that do not cross an intron-exon junction), a positive NRT signal means your “gene expression” data includes contaminating genomic DNA. Without an NRT, you cannot rule this out, and a careful reviewer will ask.

4. Replicate Structure Is Ambiguous

MIQE requires distinguishing between technical and biological replicates in the methods section. Too many papers report “n = 9” when they mean “3 biological samples, 3 technical replicates each.” These are not the same n, and the statistical tests are different.

• Technical replicates measure instrument and pipetting precision. They are averaged before statistical comparison.
• Biological replicates measure true biological variation. They are the unit of replication for statistical tests.

A reviewer reading “Student’s t-test with n = 9” and seeing 3 biological samples in the figure legend will conclude that the authors confused technical with biological replicates and inflated the sample size. This is a classic pseudo-replication error. Report both numbers explicitly: “3 biological replicates, technical triplicates, averaged before statistical comparison.”

5. The Analysis Method Is Not Specified

“Fold change was calculated” is not an analysis method. MIQE Essential requires stating which quantification method was used and why. Options include:

• Delta-delta Ct (Livak): assumes 100% efficiency for all primers, within 5% of each other
• Pfaffl method: efficiency-corrected, used when efficiencies deviate from 100% or differ between primers
• Absolute quantification (standard curve): reports copies per reaction, requires a calibrator of known concentration
• REST or similar per-sample efficiency correction: handles sample-specific efficiency variation

If you used DDCt, a reviewer will check that your reported efficiencies justified the assumption. If you used Pfaffl, they will check that efficiency values were applied correctly. Reporting the specific formula with the assumption made is the difference between a reviewer accepting the method and asking for a reanalysis.

6. Statistical Test Choice Is Unjustified

MIQE requires reporting the statistical test used for group comparisons and the software that computed it. Reviewers commonly flag:

• Running tests on fold change values instead of ΔCt values. Fold change is log-normally distributed; ΔCt is approximately normal. Parametric tests (t-test, ANOVA) must run on ΔCt, and fold change is computed afterward for display.
• Using Student’s t-test instead of Welch’s. Student’s t-test assumes equal variances. qPCR rarely has equal variance between treatment and control groups. Welch’s is the safer default.
• Missing multiple-testing correction when comparing many genes. Testing 10 genes at alpha = 0.05 gives an expected 0.5 false positives without correction.
• Reporting only p-values, not effect sizes. MIQE 2.0 added a recommendation to report effect sizes (Cohen’s d, eta-squared) alongside p-values.

7. Raw Data and Analysis Software Are Not Cited

MIQE increasingly expects:

• The specific version of the instrument software used for Ct determination
• The threshold and baseline settings (automatic vs manual)
• The analysis software used for quantification (with version)
• A statement on raw data availability (supplementary data, RDML file, public repository)

MIQE 2.0 explicitly encourages RDML (Real-time PCR Data Markup Language) raw data deposition. Even if the journal does not require it, reviewers who specialize in qPCR will ask for it, because Ct values depend on the threshold and baseline choices. Without raw fluorescence data, nobody can re-analyze your experiment with different settings.

MIQE 2.0 Raised the Bar in 2025

The 2025 revision simplified several items, removed some desirable items that turned out to add little value, and tightened expectations around a few Essential items. The most practically significant direction of change is that reporting expected in 2009 as “Desirable” is now commonly flagged by reviewers as expected—things like efficiency reporting per primer, stability metrics for reference genes, and clear separation of technical and biological replication. In effect, the ceiling of 2009 has become the floor of 2025.

The Revision-Cycle Math

A major revision cycle at a qPCR-focused journal takes 4 to 12 weeks. Covering these seven items in your first submission—with specific numbers, not narrative claims—prevents most methods-section revision requests. A MIQE-compliant methods section is roughly 600 to 900 words for a standard RT-qPCR study. That is longer than many authors expect, but it is the difference between a single review cycle and a second one.

The original MIQE paper includes the full checklist with Essential and Desirable items marked. Download it, work through it line by line as you draft the methods section, and attach it to your submission. Many journals now require the completed checklist as a supplementary file. Submitting it proactively signals to reviewers that you have done the work, which shortens their review and raises the odds of acceptance.